<DOCUMENT>
<TYPE>EX-10.30
<SEQUENCE>4
<FILENAME>j8910_ex10d30.htm
<DESCRIPTION>EX-10.30
<TEXT>
<html>

<head>

<title>  </title>

</head>

<body>

<div style="font-family:'Times New Roman';">

<p align="right" style="line-height:normal;margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 10.30</font></b></p>

<p align="right" style="line-height:normal;margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<h1 style="margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amendment # 5</font></b></h1>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">to the Research, Option and License
Agreement</font></b></p>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">dated September 29, 1994</font></b></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This
Amendment, dated this 23rd day of September, 2002, is by and between </font><font face="Wingdings" style="font-family:Wingdings;">&#140;</font>  <b><font style="font-weight:bold;">VICAL INCORPORATED</font></b>, a Delaware Corporation
(&#147;VICAL&#148;), having a place of business located at 9373 Towne Centre Drive, Suite
100, San Diego, California 91212, USA, <font face="Wingdings" style="font-family:Wingdings;">&#141;</font>  <b><font style="font-weight:bold;">AVENTIS</font></b>  <b><font style="font-weight:bold;">PASTEUR</font></b>,
a French <i><font style="font-style:italic;">Soci&#233;t&#233; Anonyme</font></i> (&#147;AvP&#148;),
having a registered head office located at 2 avenue Pont Pasteur, 69007 Lyon,
France, and <font face="Wingdings" style="font-family:Wingdings;">&#142;</font><b><font style="font-weight:bold;"> AVENTIS</font></b>  <b><font style="font-weight:bold;">PASTEUR</font></b>  <b><font style="font-weight:bold;">Limited</font></b>,
a company organized and existing under the laws of the Province of Ontario,
Canada (&#147;AvP-Canada&#148;) and having its principal place of business at Connaught
Campus, 1755 Steeles Avenue West, Toronto, Ontario, Canada M2R 3T4.</p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS,
VICAL and AvP entered into a Research, Option and License Agreement (&#147;the
Agreement&#148;) as of September 29, 1994, as amended by Amendment #1 dated as of
September 29, 1994, by Amendment # 2 dated January 26, 1996, by Amendment # 3
dated as of April 15, 1996, and by Amendment # 4 dated December 7, 2001
(&#147;Amendment # 4&#148;) under which AvP was granted Options in the Field of <i><font style="font-style:italic;">Immunotherapeutic vaccines against cancer in humans
containing the </font></i>[***] and to obtain an exclusive license under
certain Patent Rights and certain associated technologies owned by or licensed
to VICAL; and</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS,
VICAL informed AvP of its interest in reacquiring the rights related to [***];
and</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS, according
to Amendment # 4, AvP&#146;s Option Period will not expire before [***]; and</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS,
AvP agrees to return its rights to [***] to VICAL;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NOW,
THEREFORE, the parties agree to amend the Agreement as follows :</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;line-height:normal;margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>VICAL hereby requests that AvP abandons its rights to [***] before the
end of the Option Period (as defined in Amendment #&nbsp;4).</p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;line-height:normal;margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>AvP hereby agrees to abandon the Option rights with respect to [***] (as
described in point 3. of Amendment # 4), effective immediately.</p>

<p style="line-height:normal;margin:0in 0in .0001pt 21.3pt;text-indent:-21.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;line-height:normal;margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In consideration of the reversion of rights, as soon as practicable upon
execution of this Amendment # 5, VICAL will:</p>

<p style="font-size:10.0pt;line-height:normal;margin:0in 0in .0001pt .7in;text-indent:-.2in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Refund to AvP-Canada the USD [***] paid&#160; after execution of Amendment # 4; and</p>

<p style="line-height:normal;margin:0in 0in .0001pt 1.4in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="1" width="25%" noshade color="black" align="left">

</font></div>


<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[***]
Confidential material redacted and separately filed with the Commission.</font></p>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='',FILE='C:\C2\dwaszak\8910_5\t_1339317\j8910_ex10d30.htm',USER='dwasza',CD='Mar 28 15:53 2003' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;line-height:normal;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="font-size:10.0pt;line-height:normal;margin:0in 0in .0001pt .7in;text-indent:-.2in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pay to AvP an additional USD [***] for AvP&#146;s
administrative efforts since execution of Amendment # 4.</p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;line-height:normal;margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Additionally, VICAL hereby offers to AvP an Option to obtain an exclusive,
worldwide, royalty bearing license to an available cancer specific antigen
(antigen to be identified by a GenBank accession number) under the same terms
and conditions as Amendment #4.&#160; Such
Option shall expire [***] following execution of the present Amendment #5. For
the purpose of this Amendment #5, &#147;available cancer specific antigen&#148; shall
mean a cancer specific antigen that:</p>

<p style="line-height:normal;margin:0in 0in .0001pt .95in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)&#160;&#160;&#160; VICAL is not pursuing either alone or with a
Third Party; OR</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt .95in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;&#160; VICAL has not granted rights to a Third
Party.</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt 21.3pt;text-indent:-21.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;line-height:normal;margin:0in 0in .0001pt .2in;text-indent:-.2in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any provision of the Agreement not modified by this Amendment # 5 shall
remain unchanged. Capitalized terms in this Amendment # 5 shall have the
meaning set forth in the Agreement unless otherwise specified.</p>

<p style="line-height:normal;margin:0in 0in .0001pt 21.3pt;text-indent:-21.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IN WITNESS WHEREOF, the parties hereto have had this
Amendment # 5 executed by their authorized representatives as set forth below.</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="54%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:54.1%;">
  <h2 style="margin:0in 0in .0001pt;page-break-after:auto;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">VICAL INCORPORATED</font></b></h2>
  </td>
  <td width="45%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:45.9%;">
  <h2 style="margin:0in 0in .0001pt;page-break-after:auto;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">AVENTIS PASTEUR Limited</font></b></h2>
  </td>
 </tr>
 <tr>
  <td width="54%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:54.1%;">
  <h2 style="font-size:10.0pt;margin:0in 0in .0001pt;page-break-after:auto;">&nbsp;</h2>
  </td>
  <td width="45%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:45.9%;">
  <h2 style="font-size:10.0pt;margin:0in 0in .0001pt;page-break-after:auto;">&nbsp;</h2>
  </td>
 </tr>
 <tr>
  <td width="54%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:54.1%;">
  <h2 style="font-size:10.0pt;margin:0in 0in .0001pt;page-break-after:auto;">&nbsp;</h2>
  </td>
  <td width="45%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:45.9%;">
  <h2 style="font-size:10.0pt;margin:0in 0in .0001pt;page-break-after:auto;">&nbsp;</h2>
  </td>
 </tr>
 <tr>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.22%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By : </font></p>
  </td>
  <td width="16%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:16.08%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ VIJAY SAMANT</font></p>
  </td>
  <td width="34%" valign="top" style="padding:0in 0in 0in 0in;width:34.8%;">
  <p style="font-size:1.0pt;line-height:normal;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.14%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By :</font></p>
  </td>
  <td width="18%" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:18.88%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ MARK LIEVONEN</font></p>
  </td>
  <td width="23%" valign="top" style="padding:0in 0in 0in 0in;width:23.88%;">
  <p style="font-size:1.0pt;line-height:normal;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="3%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:3.98%;">
  <p style="font-size:1.0pt;line-height:normal;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.12%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vijay SAMANT</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.14%;">
  <p style="font-size:1.0pt;line-height:normal;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="42%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:42.76%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mark LIEVONEN</font></p>
  </td>
 </tr>
 <tr>
  <td width="3%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:3.98%;">
  <p style="font-size:1.0pt;line-height:normal;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.12%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President and C.E.O.</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.14%;">
  <p style="font-size:1.0pt;line-height:normal;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="42%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:42.76%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President</font></p>
  </td>
 </tr>
 <tr>
  <td width="54%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:54.1%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date : 9/23/02</font></p>
  </td>
  <td width="45%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:45.9%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date : 10/18/02</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="23" style="border:none;"></td>
  <td width="5" style="border:none;"></td>
  <td width="110" style="border:none;"></td>
  <td width="251" style="border:none;"></td>
  <td width="23" style="border:none;"></td>
  <td width="136" style="border:none;"></td>
  <td width="172" style="border:none;"></td>
 </tr>
</table>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="53%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:53.82%;">
  <h2 style="margin:0in 0in .0001pt;page-break-after:auto;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">AVENTIS PASTEUR S.A.</font></b></h2>
  </td>
  <td width="46%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:46.18%;">
  <h2 style="font-size:1.0pt;margin:0in 0in .0001pt;page-break-after:auto;">&nbsp;</h2>
  </td>
 </tr>
 <tr>
  <td width="53%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:53.82%;">
  <h2 style="font-size:10.0pt;margin:0in 0in .0001pt;page-break-after:auto;">&nbsp;</h2>
  </td>
  <td width="46%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:46.18%;">
  <h2 style="font-size:10.0pt;margin:0in 0in .0001pt;page-break-after:auto;">&nbsp;</h2>
  </td>
 </tr>
 <tr>
  <td width="53%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:53.82%;">
  <h2 style="font-size:10.0pt;margin:0in 0in .0001pt;page-break-after:auto;">&nbsp;</h2>
  </td>
  <td width="46%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:46.18%;">
  <h2 style="font-size:10.0pt;margin:0in 0in .0001pt;page-break-after:auto;">&nbsp;</h2>
  </td>
 </tr>
 <tr>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.24%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By :</font></p>
  </td>
  <td width="17%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:17.72%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/DAVE WILLIAMS</font></p>
  </td>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.86%;">
  <p style="font-size:1.0pt;line-height:normal;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.24%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By :</font></p>
  </td>
  <td width="18%" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:18.74%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ JIM TARTAGLIA</font></p>
  </td>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.2%;">
  <p style="font-size:1.0pt;line-height:normal;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="5%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:5.26%;">
  <p style="font-size:1.0pt;line-height:normal;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="48%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:48.56%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dave WILLIAMS</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.24%;">
  <p style="font-size:1.0pt;line-height:normal;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="42%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:42.94%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jim TARTAGLIA</font></p>
  </td>
 </tr>
 <tr>
  <td width="5%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:5.26%;">
  <p style="font-size:1.0pt;line-height:normal;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="48%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:48.56%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President and CEO</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.24%;">
  <p style="font-size:1.0pt;line-height:normal;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="42%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:42.94%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice-President Research</font></p>
  </td>
 </tr>
 <tr>
  <td width="53%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:53.82%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date : 10/7/02</font></p>
  </td>
  <td width="46%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:46.18%;">
  <p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date : 10/21/02</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="23" style="border:none;"></td>
  <td width="15" style="border:none;"></td>
  <td width="113" style="border:none;"></td>
  <td width="237" style="border:none;"></td>
  <td width="23" style="border:none;"></td>
  <td width="135" style="border:none;"></td>
  <td width="174" style="border:none;"></td>
 </tr>
</table>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[***]
Confidential material redacted and separately filed with the Commission.</font></p>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>


<div style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

</div>


<!-- SEQ.=1,FOLIO='2',FILE='C:\C2\dwaszak\8910_5\t_1339317\j8910_ex10d30.htm',USER='dwasza',CD='Mar 28 15:53 2003' -->
</body>

</html>

</TEXT>
</DOCUMENT>
